The benefit of aspirin therapy in type 2 diabetes: What is the evidence?

This publication has 41 references indexed in Scilit:

• AHA/ADA vs. ESC/EASD recommendations on aspirin as a primary prevention strategy in people with diabetes: how the same data generate divergent conclusions
  European Heart Journal, 2007
• Standards of Medical Care in Diabetes—2007
  Diabetes Care, 2007
• Major Outcomes in Moderately Hypercholesterolemic, Hypertensive Patients Randomized to Pravastatin vs Usual Care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)
  JAMA, 2002
• Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
  JAMA, 2002
• Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
  BMJ, 2002
• Comparison of antihypertensive treatments in preventing cardiovascular events in elderly diabetic patients
  Journal Of Hypertension, 2000
• Rationale and design of a secondary prevention trial of increasing serum high-density lipoprotein cholesterol and reducing triglycerides in patients with clinically manifest atherosclerotic heart disease (the bezafibrate infarction prevention trial)
  The American Journal of Cardiology, 1993
• European stroke prevention study: effectiveness of antiplatelet therapy in diabetic patients in secondary prevention of stroke.
  Stroke, 1992
• Thromboxane Biosynthesis and Platelet Function in Type II Diabetes Mellitus
  New England Journal of Medicine, 1990
• Final Report on the Aspirin Component of the Ongoing Physicians' Health Study
  New England Journal of Medicine, 1989